X

pharmaceuticals

Divi’s Laboratories Ltd Q1 FY23 Earnings Conference Call Insights

https://youtu.be/EPaxfKgyoZQ Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Q&A Highlights: Tushar Manudhane from Motilal Oswal asked…

Aarti Industries Ltd Q1 FY23 Earnings Conference Call Insights

https://youtu.be/CUmhEBZpLC0 Key highlights from Aarti Industries Ltd (AARTIIND) Q1 FY23 Earnings Concall Management Update: [00:05:18] AARTIIND said it has started…

Aarti Industries reported stellar performance in Q1FY23, Revenue up by 45%

On Wednesday, Aarti Industry reported its earnings for the quarter ended June 30, 2022. The revenue from operations (gross) grew…

Glenmark Life Sciences Limited Q1 FY23 Earnings Conference Call Insights

https://youtu.be/02Igs_HUAfo Key highlights from Glenmark Life Sciences Limited (GLS) Q1 FY23 Earnings Concall Q&A Highlights: [00:14:56] Neha Manpuria from Bank…

JB Chemicals & Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights

Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q1 FY23 Earnings Concall Q&A Highlights: Rahul Jeewani from IIFL Securities…

CAPLIN POINT LABORATORIES LTD (CAPPL) Q2 FY22 Earnings Concall Transcript

CAPLIN POINT LABORATORIES LTD (NSE:CAPPL) Q2 FY22 Earnings Concall dated Aug. 05, 2022 Corporate Participants: Vivek Paarthipan -- Chief Operating…

Lupin Ltd (LUPIN) Q1 FY23 Earnings Concall Transcript

Lupin Ltd (NSE: LUPIN) Q1 FY23 Earnings Concall dated Aug. 04, 2022 Corporate Participants: Kamal Kishore Sharma -- Vice Chairman…

Earnings Infographic: Dr. Lal PathLabs Q1 2023 revenue and profit decline

Dr. Lal PathLabs Ltd (NSE: LALPATHLAB), a leading provider of diagnostic and related healthcare services, has reported lower revenues and…

Piramal Enterprises Ltd Q1 FY23 Earnings Conference Call Insights

https://youtu.be/kHUXId_eoxg Key highlights from Piramal Enterprises Ltd (PEL) Q1 FY23 Earnings Concall Management Update: PEL said that it’s on track…

Torrent Pharmaceuticals Ltd Q1 FY23 Earnings Conference Call Insights

Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q1 FY23 Earnings Concall Management Update: TORNTPHARM launched four products in 1Q23 and…